BioGaia AB (publ) (FRA:BGLA)

Revenue by Geography

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013
APAC Revenue	411.89M	365.83M
APAC Revenue Growth	12.59%	20.31%
EMEA Revenue	497.31M	507.11M
EMEA Revenue Growth	-1.93%	3.12%
Americas Revenue	628.97M	549.78M
Americas Revenue Growth	14.41%	9.81%

Revenue

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013
Pediatrics Revenue	1.15B	1.09B
Pediatrics Revenue Growth	5.56%	7.87%
Adult Health Revenue	372.53M	321.29M
Adult Health Revenue Growth	15.95%	16.73%
Other Segment Revenue	11.62M	8.15M
Other Segment Revenue Growth	42.56%	5.16%

Gross Profit

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013
Pediatrics Gross Profit	871.35M	820.41M
Pediatrics Gross Profit Growth	6.21%	7.93%
Adult Health Gross Profit	245.76M	202.18M
Adult Health Gross Profit Growth	21.55%	10.40%
Other Segment Gross Profit	11.47M	8.15M
Other Segment Gross Profit Growth	40.71%	17.73%

Updated Dec 31, 2025. Data Source: Fiscal.ai.